CXCR4 and plasma cell myeloma: Our findings could potentially be extrapolated to other hematological malignancies and solid tumors where the SDF1/CXCR4 axis plays a role in disease progression and metastasis, such as lymphomas, multiple myeloma, and breast cancer.